mRNA COVD19 vaccine (Mayo Clinic)

N/A

Report date: 2022/01/14 13:23:58

Base Information

Drug NamemRNA COVD19 vaccine (Mayo Clinic)
Drug Alias NameN/A
ClassificationVaccines > Application > Prophylactic vaccineVaccines > Development/production technology > Nucleic acid vaccine > RNA vaccine
Mechanisms of ActionImmunostimulants
TargetsNot applicable
Therapy Area/IndicationsLupus Erythematosus, SystemicInflammatory Bowel DiseasesMyositis +[9] 
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPhase 1 Clinical
Highest Status in ChinaN/A
Originator CompaniesMayo Clinic
China Registration ClassN/A

Develop Information

Active CompaniesMayo Clinic
Inactive CompaniesN/A
Active IndicationsArthritis
Inactive IndicationsLupus Erythematosus, SystemicInflammatory Bowel DiseasesMyositis +[8] 

Other Information

ATC CodeN/A
Related LinksN/A